Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Allogene Therapeutics Inc’s stock clocked out at $1.19, down -0.83% from its previous closing price of $1.2. In other words, the price has decreased by -$0.83 from its previous closing price. On the day, 1.38 million shares were traded. ALLO stock price reached its highest trading level at $1.21 during the session, while it also had its lowest trading level at $1.17.
Ratios:
To gain a deeper understanding of ALLO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.71 and its Current Ratio is at 9.71. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
On March 14, 2025, Citizens JMP Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 10 ’25 when MESSEMER DEBORAH M. sold 36,885 shares for $1.42 per share. The transaction valued at 52,377 led to the insider holds 107,431 shares of the business.
MESSEMER DEBORAH M. bought 36,885 shares of ALLO for $52,391 on Jun 10 ’25. On Apr 21 ’25, another insider, Yoshiyama Annie, who serves as the SVP, Finance of the company, sold 9,601 shares for $1.41 each. As a result, the insider received 13,537 and left with 130,663 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 260289920 and an Enterprise Value of 56045816.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.34, which has changed by -0.46875 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $3.78, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is -7.81%, while the 200-Day Moving Average is calculated to be -38.58%.
Shares Statistics:
It appears that ALLO traded 3.15M shares on average per day over the past three months and 2856700 shares per day over the past ten days. A total of 218.60M shares are outstanding, with a floating share count of 149.51M. Insiders hold about 31.65% of the company’s shares, while institutions hold 66.02% stake in the company. Shares short for ALLO as of 1749772800 were 26041918 with a Short Ratio of 8.26, compared to 1747267200 on 27361306. Therefore, it implies a Short% of Shares Outstanding of 26041918 and a Short% of Float of 14.42.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Its stock is currently analyzed by 10.0 different market analysts. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$0.74 and -$1.2 for the fiscal current year, implying an average EPS of -$1.0. EPS for the following year is -$0.99, with 10.0 analysts recommending between -$0.55 and -$1.47.
